Norristown, PA, United States of America

Martin Karl Russel Burnham


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • Barto, PA (US) (2001 - 2002)
  • King of Prussia, PA (US) (2002)
  • Norristown, PA (US) (2001 - 2003)
  • Norristwon, PA (US) (2007)

Company Filing History:


Years Active: 2001-2007

Loading Chart...
42 patents (USPTO):Explore Patents

Title: Martin Karl Russel Burnham: Innovator in Antibacterial Compound Research

Introduction

Martin Karl Russel Burnham is an accomplished inventor based in Norristown, PA, holding an impressive portfolio of 42 patents. His contributions to the field of biotechnology, particularly in the development of polypeptides and their applications in screening antibacterial compounds, have made significant impacts in medical research and pharmaceutical advancements.

Latest Patents

Among his latest patents, Burnham has developed novel polypeptides and polynucleotides that facilitate the production of these polypeptides via recombinant techniques. These inventions provide valuable methods for utilizing such polypeptides in screening for antibacterial compounds. Additionally, he has focused on spo0J1 polypeptides and polynucleotides encoding this specific protein of Staphylococcus aureus, further enhancing the methods available for antibacterial compound screening.

Career Highlights

Burnham's career has been marked by his affiliation with prominent companies in the biotechnology sector, including SmithKline Beecham Corporation. His work in these environments has allowed him to leverage his expertise to innovate in the field of molecular biology and contribute to advancements in healthcare.

Collaborations

Throughout his career, Burnham has collaborated with notable professionals such as John Edward Hodgson and Patrick Vernon Warren. These partnerships have enriched his endeavors, fostering a collaborative spirit and shared expertise in their research initiatives.

Conclusion

Martin Karl Russel Burnham remains a noteworthy figure in the realm of antibacterial research and biotechnology. With an extensive patent portfolio and a history of meaningful collaborations, his contributions continue to influence the development of new therapeutics and methods in medical science. His ongoing commitment to innovation ensures that his work will remain significant in the pursuit of effective antibacterial solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…